Medical Nutrition Market Analysis

Medical nutrition improves metabolic outcomes, provides appropriate energy to maintain desirable body weight, and helps in the development of overall health through optimal nutrition. The overall goal of medical nutrition is to assist and facilitate lifestyle and behavior changes that will lead to improved metabolic control. Medical nutrition products are used under medical supervision. There are various Oral Nutritional Supplements (ONS) which provide macronutrients and micronutrients. ONS are available as ready-to-drink liquids or powders that can be prepared as drinks. While, Parenteral Nutrition also known as 'intravenous feeding' is a method of getting nutrition directly into the blood circulation, bypassing the gastrointestinal tract.

Global medical nutrition market is estimated to be valued at US$ 13,554.5 million in 2022 and is expected to exhibit a CAGR of 5.8% during the forecast period (2022-2030).

Figure 1.Global Medical Nutrition Market Share (%), by Route of Administration, 2022

Global Medical Nutrition Market- Drivers

The increasing number of product launches through manufacturers are expected to drive the global medical nutrition market growth during the forecast period. For instance, in September 2020, Baxter, a healthcare company, announced the U.S. FDA (Food and Drug Administration) approval of Clinimax and Clinimax E. This Clinimax and Clinimax E injections are new formulations of amino acids with electrolytes in dextrose and amino acids with electrolytes in dextrose and calcium respectively. These are the higher proteins for patients requiring parenteral nutrition which helps reducing malnutrition and may include proteins (amino acids), carbohydrates, lipids (fats), electrolytes, vitamins and other trace elements.

Furthermore, in March 2020, Conagen Inc., a biotechnology company focused on bio-production of ingredients for food, pharmaceutical, and renewable materials industries developed a sustainable proprietary lactoferrin protein that reflects the nutritional properties of lactoferrin from breast milk. The lactoferrin protein is first of its kind and produced via fermentation process at commercial scale.

Medical Nutrition Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 13,554.5 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	5.8%	2030 Value Projection:	US$ 21,207.3 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Nutrition Type: Proteins, Carbohydrates, Multi-Vitamins and Antioxidants, Amino Acid, Fibers, Minerals, Others By Patient Type: Infant Nutrition, Adult Nutrition, Geriatric Nutrition By Indication: Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, Others By Route of Administration: Oral, Enteral, Parenteral By End User: Hospitals, Home Care Settings, Long Term Care, Ambulatory Surgical Centers
Companies covered:	Abbott, Baxter, Danone S.A., Nestlé, GSK Plc, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd, BASF SE, and DSM
Growth Drivers:	Increasing number of product launches Rising prevalence of chronic diseases Government initiatives and investment & funding for medical nutrition research
Restraints & Challenges:	Side effects and high cost of nutritional products Lack of awareness among the low-and- middle income countries

Figure 2.Global Medical Nutrition Market Share (%), by Region, 2022

Global Medical Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in more than 622,389,418 infected individuals worldwide as of 18th October, 2020.

The COVID-19 pandemic has significance impact on medical nutrition market, due to the changes in nutritional behavior and, conversely, how nutrition could modulate the epidemiology of COVID-19. For instance, in June 2021, a paper was published by National Center for Biotechnology Information, which suggested that COVID-19 pandemic has significant morbidity, mortality, social and financial implications for the global population and how, COVID-19 infection affects quality of life resulting from changes in nutritional behavior. Thus nutritional status of a person can modulate infectious disease and the inflammatory processes associated with it positively or negatively by altering the immune system and the malnutrition in disadvantaged populations while in elderly clearly leaves these populations more susceptible to COVID-19 infections and more severe clinical symptoms and outcomes.

Global Medical Nutrition Market: Key Developments

In September 2022, Abbott, a healthcare company to provide science-based nutrition products that provide nutritional support for patient growth, recovery, and sustainability, launched New Ensure, a science-based nutritional supplement formulated with 32 vital nutrients, which contains high quality protein, calcium and vitamin D. It also contain a special ingredients called HMB or β-hydroxy-β-methyl butyrate which helps improve muscle and bone strength. HMB is naturally produced when body breakdowns leucine, and found in foods like grapefruit, avocado, cauliflower, etc., but sometimes it is difficult to get enough HMB through food to support declining muscle health, which is  the reason it often suggested to consume nutrition supplements.

In September 2021, Sun Pharmaceutical Industries Ltd., a generic pharmaceutical company, launched Revital Nxt, a nutrition Bar, Revital NXT is  contains the goodness of Natural Ginseng, 16 vitamins & minerals and triple blend protein. Revital Nxt, is a nutritional supplement powered with natural Ginseng, a multivitamin supplement which will helps to stay active and improve mental vitality and concentration.

Global Medical Nutrition Market: Restraint

The major factors restraining growth of the medical nutrition market are side effects and complications caused by products indicated for medical nutrition. For instance, in September 2020, data was provided by National Institute of Health, according to which nutritional supplements contains some active ingredients which can strongly affect our body and most likely to have side effects, if we take higher doses instead of prescribed medicines. These dietary supplements may increase the risk of bleeding if taken to surgery and can change response to anesthesia.

Global Medical Nutrition Market market- Key Players

Major players operating in the global medical nutrition market include Abbott, Baxter, Danone S.A., Nestlé, GSK Plc, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd, BASF SE and DSM .